Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia-Reference-Cited by-同舟云学术

Effect of Medications on Physical Function and Cognition in Nursing Home Residents with Dementia

Published:2014-05-13 Issue:6 Volume:62 Page:1046-1055
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Dutcher Sarah K.¹,Rattinger Gail B.²,Langenberg Patricia³,Chhabra Pankdeep T.¹,Liu Xinggang⁴,Rosenberg Paul B.⁵⁶,Leoutsakos Jeannie-Marie⁵⁶,Simoni-Wastila Linda¹,Walker Loreen D.¹,Franey Christine S.¹,Zuckerman Ilene H.⁷

Affiliation:

1. Pharmaceutical Health Services Research Department; School of Pharmacy; University of Maryland Baltimore; Baltimore Maryland

2. Pharmacy Practice Division; School of Pharmacy; Fairleigh Dickinson University; Florham Park New Jersey

3. Department of Epidemiology and Public Health; School of Medicine; University of Maryland Baltimore; Baltimore Maryland

4. Hospital to Home; Philips Healthcare; Baltimore Maryland

5. Department of Psychiatry and Behavioral Sciences; Johns Hopkins Bayview Medical Center; Baltimore Maryland

6. Division of Geriatric Psychiatry and Neuropsychiatry; School of Medicine; The Johns Hopkins University; Baltimore Maryland

7. Health Division; IMPAQ International; Columbia Maryland

Funder

National Institutes of Health (NIH) Institutional Career Development Grant

National Institutes on Aging Training Grant

American Foundation for Pharmaceutical Education Predoctoral Fellowship

Eli Lilly and Company

Merck & Co., Inc.

Élan Corporation

Pfizer Inc.

Functional Neuromodulation Ltd.

NIH Grants

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.12838/fullpdf

Reference50 articles.

1. 2012 Alzheimer's disease facts and figures;Alzheimer's Association;Alzheimers Dement,2012

2. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline;Raina;Ann Intern Med,2008

3. Donepezil preserves cognition and global function in patients with severe Alzheimer disease;Black;Neurology,2007

4. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease;Feldman;Neurology,2001

5. Memantine in moderate-to-severe Alzheimer's disease;Reisberg;N Engl J Med,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psilocybin for the treatment of Alzheimer’s disease;Frontiers in Neuroscience;2024-07-10

2. Associations between psychotropic and anti-dementia medication use and falls in community-dwelling older adults with cognitive impairment;Archives of Gerontology and Geriatrics;2023-11

3. Identifying predictors of cognitive decline in long-term care: a scoping review;BMC Geriatrics;2023-09-05

4. Delirium, changes in cognitive function, and risk of diagnosed dementia after kidney transplantation;American Journal of Transplantation;2022-12

5. Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials;Journal of Psychiatric Research;2022-11